Masimo (MASI)
(Delayed Data from NSDQ)
$135.69 USD
+1.84 (1.37%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $135.63 -0.06 (-0.04%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth F Momentum D VGM
Brokerage Reports
0 items in cart
Masimo Corporation [MASI]
Reports for Purchase
Showing records 201 - 220 ( 484 total )
Company: Masimo Corporation
Industry: Medical - Instruments
Masimo continued strong bottom-line performance streak, maintain HOLD
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Masimo Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Masimo Corporation
Industry: Medical - Instruments
3Q Beat and 2016 Raise on Strong Core SET Growth, Margin Expansion
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Masimo Corporation
Industry: Medical - Instruments
MASI''s Solid 3Q16 Results Are A Breath Of Fresh Air To A Challenging MedTech EPS Season; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
Highlights from JNJ''s 3Q16 Results Bode Well for the MedTech Sector; Most Positive Read
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
3Q16 Preview: Stable Growth Trends Through The End of 2016
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Underlying Growth Fuels Topline Beat and Raise; Increasing PT to $63 and Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
2Q Beat and 2016 Raise on Strong Core SET Acceleration; Buy
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Masimo Corporation
Industry: Medical - Instruments
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Masimo Corporation
Industry: Medical - Instruments
Highlights from J-J''s 2Q16 Results Bode Well for the MedTech Sector; Most Positive Read Through for MASI, ISRG
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
Medical Devices: 2Q16 MedTech Preview: Stable Trends and Healthy Underlying Fundamentals
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
CEO Confident and Upbeat During Wedbush Meetings; Reiterate Outperform and Increasing PT to $60
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Q1 beats handily, guidance raised, Cercacor deconsolidated target to $47.50
Provider: Feltl & Company
Analyst: HAYNOR B